[Portal vein embolization--increased chance for liver resecability for malignancies]. 2007

V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
Chirurgická klinika, FN Plzen-Lochotín, LF UK v Plzni. liska@fnplzen.cz

BACKGROUND Liver surgery for liver malignancy is recently limited not by technical possibilities but by physiological reserves of liver parenchyma. Portal vein embolization (PVE) is performed to increase future liver remnant volume (FLRV) to extend the possibilities of liver resections. The authors evaluate the cohort of patients, that underwent PVE and confront them with the cohort of patients that underwent liver resection without PVE. METHODS At the Department of Surgery and Departement of Radiology, University Hospital Pilsen there were performed successfully PVE at 24 patients between January 2001 and August 2006. The increase of FLRV was sufficient at 17 patients. The mean period between PVE and computed tomography volumetry was 29 days. The mean period between PVE and surgical procedure was 54 days. 8 patients underwent radical liver surgery (right hepatectomy, extended right hepatectomy, combination of right hepatectomy with RFA in left lobe), 3 patients underwent radiofrequency ablation, the rest of patients was explored. For comparison we used cohort of 107 patients that underwent one step radical surgery for malignancy. RESULTS 1 year survival rate after liver operation was 85.7%, 3 years survival rate 42.9%. Disease free interval (DFI) was counted only for group of radicaly operated patients. One year DFI was 40%, two year DFI was 20%. The number of leasions was not proved as statistically significant for DFI or survival rate. In non PVE group 1 year survival rate was 78.9%, 3 years survival rate was 34.0%, one year DFI was 60.2%, two years DFI was 36.6%. CONCLUSIONS The survival rate was higher in PVE group, the DFI was shortened in PVE group. In our cohort we could conclude, the PVE increase survival rate instead of shortened DFI. PVE spreads possibilities for liver resections at patients with small FLVR and enables radical surgical therapy for patients, that will be leaved a palliative surgery or oncological therapy.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
January 2006, Hepato-gastroenterology,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
June 2008, Seminars in interventional radiology,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
February 1999, Journal of gastroenterology,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
January 2009, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
June 2008, Seminars in interventional radiology,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
September 2012, Annals of surgery,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
January 2013, Ugeskrift for laeger,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
August 2017, Langenbeck's archives of surgery,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
September 2008, Annals of surgery,
V Liska, and V Treska, and H Mírka, and M Novák, and F Slauf, and T Skalický, and A Sutnar, and S Kormunda
February 2023, Chirurgie (Heidelberg, Germany),
Copied contents to your clipboard!